MedTrace Logo

Incentive Training Role in Treatment of Hand Dexterity in Patients With Stroke

NCT07027787 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-06-19

No results posted yet for this study

Summary

Attention and hand dexterity are interdependent, with deficits in one often worsening the other. Post-stroke, reduced attention impairs hand dexterity, hindering daily activities, while poor hand function further limits attentional focus. Despite progress in rehabilitation, strategies addressing both remain limited. Purpose: This study explored the impact of incentive-based attention training on hand dexterity in stroke patients.

Conditions

Interventions

BEHAVIORAL

Standard Physical Therapy for Hand Dexterity in Stroke Patients

Standard physical therapy program for stroke patients targeting hand dexterity. Conducted 3 times/week for 8 weeks (60 min/session), exercises included wrist and forearm movements, object manipulation, ball gripping, and putty-based hand strengthening.

BEHAVIORAL

Rehacom Attention Training + Physical Therapy

Combined intervention: 30 minutes of computerized attention training using the Rehacom system, followed by 30 minutes of standard hand dexterity physical therapy. Conducted 3 times/week for 8 weeks. Rehacom provided task-based cognitive training with visual, auditory, and performance feedback in a controlled lab setting.

Sponsors & Collaborators

  • Princess Nourah Bint Abdulrahman University

    collaborator OTHER

  • Keele University

    collaborator OTHER

  • Cairo University

    collaborator OTHER

  • Queen Margaret University

    collaborator OTHER

  • Delta University for Science and Technology

    collaborator OTHER

  • Misr University for Science and Technology

    collaborator OTHER

  • South Valley University

    lead OTHER

Principal Investigators

  • Reem M Alwhaibi, master · College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07027787 on ClinicalTrials.gov